Overview
The fund invests globally in a broadly diversified portfolio of actively and passively managed instruments as well as individual investments.
The fund invests in equities, bonds, money market instruments, real estate and other alternative investments and observes the investment regulations contained in the Federal Act on Occupational Retirement, Survivors and Disability Pension Plans (OPA) and the corresponding Occupational Pension Ordinances (OPO2).
Benefits
Flexible use of funds upon retirement.
Investors can benefit globally from diversified market opportunities across asset classes and individual securities as well as across asset managers and investment styles. The investment focus is on Switzerland.
Pursue pension savings goals while at the same time promoting sustainable investing through ESG criteria.
Risks
Features
| Product category |
UBS Privilege Funds
|
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
November 1, 2019
|
| Currency of account |
CHF
|
| Close of financial year |
December 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.78% p.a.
|
| Management fee |
0.60% p.a.
|
| Total expense ratio (TER) |
0.80% p.a.
|
| Minimum investment |
n.a.
|
| Securities no. |
48232425
|
| ISIN |
CH0482324255
|
| Bloomberg Ticker |
CCPRVEA SW
|
| Reuters Id |
48232425X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 1.40 | 2.81 | 2.51 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 6.03 | 6.94 | 21.29 |
| 3Y | |||
| 5Y | 11.81 | 34.60 | 30.82 |
| ø p.a.5Y | 2.26 | 6.12 | 5.52 |
Current data
| Net asset value | 23.04.2026 | CHF 1,163.13 |
| High - last 12 months | 25.02.2026 | CHF 1,185.88 |
| Low - last 12 months | 28.04.2025 | CHF 1,077.65 |
| Last distribution | 20.03.2026 | CHF 13.60 |
| Assets of the unit class in mn | 23.04.2026 | CHF 29.46 |
| Total product assets in mn | 23.04.2026 | CHF 906.35 |
| Theoretical yield to maturity (gross) | 31.03.2026 | 1.70% |
| Modified duration | 31.03.2026 | 2.05 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| UBS MSCI USA Selection UCITS ETF | 10.58 |
| UBS Lux Bond SICAV - USD Investment Grade Corporates USD | 6.09 |
| UBS CH Institutional Fund 4 - Real Estate Switzerland Securities NSL | 4.68 |
| UBS Lux Bond SICAV - EUR Corporates EUR | 4.15 |
| UBS S&P 500 Scored & Screened UCITS ETF | 4.11 |
| Roche Holding AG | 3.67 |
| UBS MSCI EM SLECTON-INFDUSQX | 3.67 |
| Nestle SA | 3.16 |
| Novartis AG | 2.96 |
| Pfandbriefbank schweizerischer Hypothekarinstitute AG | 2.36 |
Fees
Distributions
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Tax domicile CH gross amount
|
Tax domicile CH net amount
|
Tax domicile not CH gross amount
|
Tax domicile not CH net amount
|
|
| 18.03.2026 | 20.03.2026 | 12 | CHF | 13.60 | 8.84 | 13.60 | 8.84 |
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|